Chemours Co (CC) 8-K Current Report: February 26, 2026
Filed: February 26, 2026
Health Care
Chemicals & Allied ProductsChemours Co (CC) 8-K current report filed with SEC EDGAR on February 26, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.
Reported 8-K Items1 item
- Item 8.01: Other Events
Chemours Co 8-K Feb 26, 2026 Event Analysis
Item 8.01 · Other Events
- • $700M senior unsecured notes at 7.875% due 2034, priced in private offering exempt from Securities Act registration
- • Deal upsized by $100M from initial $600M target — strong investor demand signal
- • High 7.875% coupon reflects CC's non-investment-grade credit profile and current rate environment
- • Unsecured structure means noteholders rank behind secured creditors in any distress scenario
Other Chemours Co 8-K Filings
Get deeper insights on Chemours Co
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.